Search Results | Diabetes | American Diabetes Association

1-14 of 14

Sort by

Sort Order Select

Meeting Abstracts

206-LB: Indian Americans as Compared with Indians Exhibit Increased Beta-Cell Responsivity and Insulin Clearance in Absence of Changes in Insulin Sensitivity

VEDAVATI PURANDARE, ALFONSO GALDERISI, MARIANGELA MAERTINO, ANANDA BASU, CLAUDIO COBELLI, AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, RITA BASU

Diabetes 2021;70(Supplement_1):206-LB

DOI: https://doi.org/10.2337/db21-206-LB

Published: 01 June 2021

View article

Meeting Abstracts

1095-P: Glycemic Trend in Metropolitan versus Non-metropolitan Cities of India: One-Year Results of LANDMARC

Diabetes 2021;70(Supplement_1):1095-P

DOI: https://doi.org/10.2337/db21-1095-P

Published: 01 June 2021

View article

Meeting Abstracts

1087-P: Therapy Trends at One Year in the Longitudinal LANDMARC Study on Real-World Outcomes in Type 2 Diabetes Patients in India

Diabetes 2021;70(Supplement_1):1087-P

DOI: https://doi.org/10.2337/db21-1087-P

Published: 01 June 2021

View article

Meeting Abstracts

1065-P: Glycemic Trend at One Year in a Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India (LANDMARC)

Diabetes 2021;70(Supplement_1):1065-P

DOI: https://doi.org/10.2337/db21-1065-P

Published: 01 June 2021

View article

Meeting Abstracts

1033-P: Complications at One Year in a Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India (LANDMARC)

Diabetes 2021;70(Supplement_1):1033-P

DOI: https://doi.org/10.2337/db21-1033-P

Published: 01 June 2021

View article

Meeting Abstracts

1041-P: Diabetes Complications among Patients from Metropolitan vs. Non-metropolitan Cities in India: One-Year Results of LANDMARC

Diabetes 2021;70(Supplement_1):1041-P

DOI: https://doi.org/10.2337/db21-1041-P

Published: 01 June 2021

View article

Meeting Abstracts

1582-P: Glycemic Change from Baseline in the First Large-Scale Longitudinal Nationwide Study on Management and Real-World Outcomes of Diabetes in India (LANDMARC)

ROMIK GHOSH, ASHOK K. DAS, AMBRISH MITHAL, SHASHANK JOSHI, K.M. PRASANNA KUMAR, SANJAY KALRA, AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, HEMANT THACKER, BIPIN SETHI, SENTHILNATHAN MOHANASUNDARAM, SHALINI K. MENON, ARJUN NAIR, NADEEM RAIS, SUBHASH KUMAR WANGNOO, SUBHANKAR CHOWDHURY, ABDUL H. ZARGAR

Diabetes 2020;69(Supplement_1):1582-P

DOI: https://doi.org/10.2337/db20-1582-P

Published: 01 June 2020

View article

Meeting Abstracts

1588-P: Therapy Trends in Initial 6 Months of the First Large-Scale Longitudinal Nationwide Study on Management and Real-World Outcomes of Diabetes in India (LANDMARC)

Diabetes 2020;69(Supplement_1):1588-P

DOI: https://doi.org/10.2337/db20-1588-P

Published: 01 June 2020

View article

Meeting Abstracts

2271-PUB: Rate of Diabetes Complications during the Initial 6 Months of the First Large-Scale Longitudinal Nationwide Study on Management and Real-World Outcomes of Diabetes in India (LANDMARC)

ROMIK GHOSH, ASHOK K. DAS, SHASHANK JOSHI, AMBRISH MITHAL, PRASANNA KUMAR, SANJAY KALRA, AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, HEMANT THACKER, BIPIN SETHI, SENTHILNATHAN MOHANASUNDARAM, SHALINI K. MENON, ARJUN NAIR, NADEEM RAIS, SUBHASH KUMAR WANGNOO, SUBHANKAR CHOWDHURY, ABDUL H. ZARGAR

Diabetes 2020;69(Supplement_1):2271-PUB

DOI: https://doi.org/10.2337/db20-2271-PUB

Published: 01 June 2020

View article

Meeting Abstracts

2258-PUB: Impact of Cardiovascular (CV) Risk Factors during the Initial 6 Months of the First Large-Scale Longitudinal Nationwide Study on Management and Real-World Outcomes of Diabetes in India (LANDMARC)

ROMIK GHOSH, ASHOK K. DAS, SHASHANK JOSHI, AMBRISH MITHAL, K.M. PRASANNA KUMAR, SANJAY KALRA, AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, HEMANT THACKER, BIPIN SETHI, SENTHILNATHAN MOHANASUNDARAM, SHALINI K. MENON, ARJUN NAIR, NADEEM RAIS, SUBHASH KUMAR WANGNOO, SUBHANKAR CHOWDHURY, ABDUL H. ZARGAR

Diabetes 2020;69(Supplement_1):2258-PUB

DOI: https://doi.org/10.2337/db20-2258-PUB

Published: 01 June 2020

View article

Meeting Abstracts

2213-PUB: Management Practices in Indian Type 2 Diabetes Mellitus (T2DM) Participants With or Without Comorbidities in Real-World LEADD (Learnings with Experts to Advance Diabetic Dyslipidemia Management) Study

AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, ASHOK KUMAR DAS, BANSHI D. SABOO, SANJAY KALRA

Diabetes 2019;68(Supplement_1):2213-PUB

DOI: https://doi.org/10.2337/db19-2213-PUB

Published: 01 June 2019

View article

Meeting Abstracts

2249-PUB: Current Practices and Gaps in Management of Dyslipidemia in Indian Participants with Type 2 Diabetes Mellitus (T2DM) in Alignment with American Association of Clinical Endocrinologists (AACE) Guidelines in LEADD (Learning with Experts to Advance Diabetes

AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, ASHOK KUMAR DAS, BANSHI D. SABOO, SANJAY KALRA, VAGEESH AYYAR, MANGESH HARIHAR TIWASKAR

Diabetes 2019;68(Supplement_1):2249-PUB

DOI: https://doi.org/10.2337/db19-2249-PUB

Published: 01 June 2019

View article

Meeting Abstracts

1551-P: Baseline Characteristics of Patients in the First Pan-India, Prospective, Longitudinal Study to Assess Management and Outcomes of T2D in Real-World Settings—LANDMARC

ROMIK GHOSH, ASHOK KUMAR DAS, AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, SANJAY KALRA, HEMANT THACKER, LANDMARC STUDY GROUP

Diabetes 2019;68(Supplement_1):1551-P

DOI: https://doi.org/10.2337/db19-1551-P

Published: 01 June 2019

View article

Meeting Abstracts

617-P: Current Practices and Gaps in Management of Type 2 Diabetes Mellitus (T2DM) with Dyslipidemia as per American Diabetes Association (ADA) Guidelines Subset Analysis from LEADD (Learning with Experts to Advance Diabetic Dyslipidemia Management) Study

AMBIKA GOPALAKRISHNAN UNNIKRISHNAN, ASHOK KUMAR DAS, BANSHI D. SABOO, SANJAY KALRA, VAGEESH AYYAR, MANGESH HARIHAR TIWASKAR

Diabetes 2019;68(Supplement_1):617-P

DOI: https://doi.org/10.2337/db19-617-P

Published: 01 June 2019

View article

NARROW

206-LB: Indian Americans as Compared with Indians Exhibit Increased Beta-Cell Responsivity and Insulin Clearance in Absence of Changes in Insulin Sensitivity

1095-P: Glycemic Trend in Metropolitan versus Non-metropolitan Cities of India: One-Year Results of LANDMARC

1087-P: Therapy Trends at One Year in the Longitudinal LANDMARC Study on Real-World Outcomes in Type 2 Diabetes Patients in India

1065-P: Glycemic Trend at One Year in a Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India (LANDMARC)

1033-P: Complications at One Year in a Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India (LANDMARC)

1041-P: Diabetes Complications among Patients from Metropolitan vs. Non-metropolitan Cities in India: One-Year Results of LANDMARC

1582-P: Glycemic Change from Baseline in the First Large-Scale Longitudinal Nationwide Study on Management and Real-World Outcomes of Diabetes in India (LANDMARC)

1588-P: Therapy Trends in Initial 6 Months of the First Large-Scale Longitudinal Nationwide Study on Management and Real-World Outcomes of Diabetes in India (LANDMARC)

2271-PUB: Rate of Diabetes Complications during the Initial 6 Months of the First Large-Scale Longitudinal Nationwide Study on Management and Real-World Outcomes of Diabetes in India (LANDMARC)

2258-PUB: Impact of Cardiovascular (CV) Risk Factors during the Initial 6 Months of the First Large-Scale Longitudinal Nationwide Study on Management and Real-World Outcomes of Diabetes in India (LANDMARC)

2213-PUB: Management Practices in Indian Type 2 Diabetes Mellitus (T2DM) Participants With or Without Comorbidities in Real-World LEADD (Learnings with Experts to Advance Diabetic Dyslipidemia Management) Study

2249-PUB: Current Practices and Gaps in Management of Dyslipidemia in Indian Participants with Type 2 Diabetes Mellitus (T2DM) in Alignment with American Association of Clinical Endocrinologists (AACE) Guidelines in LEADD (Learning with Experts to Advance Diabetes

1551-P: Baseline Characteristics of Patients in the First Pan-India, Prospective, Longitudinal Study to Assess Management and Outcomes of T2D in Real-World Settings—LANDMARC

617-P: Current Practices and Gaps in Management of Type 2 Diabetes Mellitus (T2DM) with Dyslipidemia as per American Diabetes Association (ADA) Guidelines Subset Analysis from LEADD (Learning with Experts to Advance Diabetic Dyslipidemia Management) Study

Email alerts

Journals

Books

News

Other

About

Resources

Email alerts

Journals

Books

News

Other

About

Resources

This Feature Is Available To Subscribers Only